Even if clinical trials suggest tolerability, the real-world risk profile changes when: the source and purity of the peptide are uncertain, its used in different routes than studied, its used in stacked protocols with other drugs, its used in populations the trials didnt represent
Hi Zayne from Australia
One COA proves the blend is pharmaceutical grade. A meaningful blend assessment requires separate identity, quantity, ratio, impurity and stability evidence
Without these large-scale studies, we have virtually no reliable information on how BPC-157 affects the human body
That said, most people start to notice results soon after beginning the dosing cycle, which is typically prescribed for between six to 12 weeks
Patients with more severe or longstanding deficiency may take longer to notice the full benefit